Do you have questions about the market access of medical devices and the benefit assessment of medical devices? Then you have come to the right place. Market access and the reimbursement of medical devices in the outpatient and inpatient sector represents a challenge from a reimbursement perspective due to the diversity of medical devices. For example, it must be clarified whether and how medical devices are reimbursable and which measures must be taken for reimbursement.
Since the introduction of the testing rule according to § 137e SGB V and the benefit assessment for medical devices of risk classes 2b and 3 in the inpatient area as a new examination and treatment method, complex application procedures have been established which represent opportunities and risks. We support you in market access and reimbursement of medical devices, especially when it comes to evaluating the potential and benefits of new innovative medical devices. Use our competence for an optimal market access of your products.